Blackstone Inc (BX) Actualités

Form 4 - Statement of changes in beneficial ownership of securities

Form S-8 - Securities to be offered to employees in employee benefit plans

Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Blackstone Appoints Rodney Zemmel as Global Head of Portfolio Operations

Blackstone (NYSE: BX) announced today that Rodney Zemmel – a long-time Senior Partner at McKinsey, who served as the global leader of both...

Element Fleet Management and Blackstone Announce Strategic Funding Relationship

Initial transaction includes approximately CAD $500 million portfolio Element Fleet Management Corp. (TSX:EFN) ("Element"), the largest publicly...

Blackstone Announces $5.6 Billion Final Close for Blackstone Energy Transition Partners IV at Hard Cap

Blackstone (NYSE: BX) today announced the final close for its energy-transition-focused private equity fund, Blackstone Energy Transition...

Blackstone Infrastructure to Acquire Safe Harbor Marinas in $5.65B Transaction

Blackstone (NYSE: BX) announced today that funds managed by Blackstone Infrastructure (“Blackstone”) have agreed to acquire Safe Harbor Marinas...

Form 4 - Statement of changes in beneficial ownership of securities

Form 13F-HR - Quarterly report filed by institutional managers, Holdings

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Blackstone Real Estate Completes Privatization of Retail Opportunity Investments Corp. for $4 Billion

Blackstone (NYSE: BX) and Retail Opportunity Investments Corp. (“ROIC” or the “Company”) today announced that Blackstone Real Estate Partners X...

Blackstone Life Sciences et Anthos Therapeutics annoncent la conclusion d’un accord portant sur l’acquisition d’Anthos par Novartis pour un montant qui pourrait atteindre 3,1 milliards USD

Cette annonce met l’accent sur le potentiel que possède la nouvelle classe de médicaments inhibiteurs du facteur XI d’améliorer la prévention des...

Blackstone Life Sciences and Anthos Therapeutics Announce Agreement for Anthos to be Acquired by Novartis for up to $3.1 Billion

Reflects the promise of the novel Factor XI inhibitor class of medicines to help prevent strokes and other conditions as well as Abelacimab’s...